Effect of Fu's subcutaneous needling therapy on abnormal uterine bleeding

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000002923

Enrollment

Unknown

Registered

2020-01-15

Start date

2020-02-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abnormal uterine bleeding

Interventions

2:Fu's subcutaneous needling therapy

1:non-intervention

Eligibility

Sex/Gender

Female

Age

20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-45 years old; 2. Preoperative diagnosis of benign gynecological disease; 3. Laparoscopic or uterine laparoscopic surgery was planned, and there was no vaginal bleeding before the operation

Exclusion criteria

Exclusion criteria: 1. Patients without postoperative vaginal bleeding were excluded; 2. Postoperative pathological diagnosis of malignant tumors, such as cervical cancer, ovarian cancer and endometrial cancer, was excluded 3. Exclude pregnancy-related diseases such as ectopic pregnancy; 4. Excluded patients after total hysterectomy; 5. Exclude patients with cervical lesions; 6. Exclude patients with vaginal bleeding caused by blood diseases and immune diseases.

Design outcomes

Primary

Measure	Time frame
blood loss of uterus;	—

Countries

China

Contacts

Public ContactWenpei Bai

Bwpbjsjt@126.com+86 18801230761

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026